实用肿瘤学杂志 ›› 2011, Vol. 25 ›› Issue (3): 242-245.doi: 10.3969/j.issn.1002-3070.2011.03.010

• 论著 • 上一篇    下一篇

肺癌患者血浆中凝血及纤溶指标的水平与其临床病理特征的关系

张同梅, 鲁葆华, 贾红彦, 王敬萍, 李宝兰   

  1. 首都医科大学附属北京胸科医院综合科(北京 101149)
  • 收稿日期:2011-01-10 出版日期:2011-03-25 发布日期:2012-02-21
  • 通讯作者: 王敬萍,E-mail:amelia0829@163.com
  • 作者简介:张同梅,女,(1974-),硕士,主治医师,从事胸部肿瘤的临床及科研工作

The relationship between the plasma level of coagulation and fibrinolysis indexes in lung cancer patients and the clinicopathological characterictics

ZHANG Tongmei,LU Baohua,JIA Hongyan,WANG Jingping,LI Baolan   

  1. Department of General Surgery,Beijing Chest Hospital Affiliated to Capital Medical University,Beijing 101149
  • Received:2011-01-10 Online:2011-03-25 Published:2012-02-21

摘要: 目的 探讨凝血及纤溶指标在不同病理类型、分期及治疗状态的肺癌患者中的表达及其意义。方法 用ELISA法对62例初治和治疗后肺癌患者血浆中血小板(PLT)、凝血酶原时间(PT)、活化的部分凝血酶原激活时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FIB)、D二聚体(D-D)和尿激酶型纤溶酶原激活物(uPA)及其受体(uPAR)和组织纤溶酶原激活物(tPA)进行检测。结果 PLT、PT、APTT和TT的含量在不同分期、不同病理类型和不同治疗状态的患者中差异无统计学意义(P>0.05)。FIB在Ⅳ期和小细胞肺癌患者血浆中含量高于其他分期和类型患者,P值分别为0.028和0.005,差异有统计学意义;D-D在腺癌患者血浆中含量较其他类型患者有升高,P=0.005,差异有统计学意义。uPAR在腺癌患者血浆中水平低于其他类型患者,在Ⅲ期患者血浆中高于Ⅳ期患者,而治疗后患者血浆uPAR的水平低于未治疗者,P值分别为0.03、0.045和0.007,差异有统计学意义;tPA在小细胞癌患者血浆中含量高于其他类型,P值0.04,差异有统计学意义。结论 治疗后患者血浆uPAR的水平低于未治疗患者;腺癌患者血浆D-D含量高于其他类型患者;不同病理类型和不同临床分期肺癌患者表达凝血及纤溶指标的种类和数量不同。

Abstract: Objective To study the expression and significance of coagulation and fibrinolysis indexes in lung caner patients with different pathology types、stages and therapeutic states.Method The plasma levels of platelet(PLT),prothrobin time(PT),activated partial thromboplastin time(APTT),throbin time(TT),D-dimer(D-D),fibrinogen(FIB),tissue type plasminogen activator(tPA) and urokinase type plasminogen activator(uPA)and urokinase plasminogen activator receptor(uPAR)were measured by ELLISA technique in 62 lung cancer patients before and after therapy.Result The levels of PLT,PT,APTT,TT were no difference in all kinds of patients(P>0.05).The levels of FIB were significantly higher in patients with Ⅳ stage and small cell lung cancer(SCLC)than those in other stages and types (P=0.028 and P=0.005,respedida)and 0.005 and the differences have statistical significance.The level of D-D was higher in adenocarcinoma than those in other types(P=0.005).The level of uPAR was lower in adenocarcinoma than those in other types and higher in Ⅲ stage patients than Ⅳ stage,bat the uPAR levels of patients who received operation and chemotherapy were lower than those not receiving any therapy (P=0.03,P=0.045 and P=0.007,respedively).The tPA level was higher in SCLC than those in other types(P=0.04).Conclusion The plasma level of UPAR was lower in patients who received any therapy than those not.The plasma of D-dimer is higher in adenocarcinoma patients than those in other type patients;Different type and clinical stage of lung cancer expressed different coagulation and fibrinolysis factors and quantity.

中图分类号: